Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice

Apoptosis

Volumn 16, Issue 4, 2011, Pages 370-381

  Mu, Bo ^a,b   Yang, Jin Liang ^a   Gou, Lan Tu ^a   Yao, Yu Qin ^a   Zhou, Yan ^a   Cheng, Zhi Hui ^a   Shi, Hua Shan ^a   Li, Zhi Yong ^a   Wen, Yuan ^a   Leng, Fei ^a   Cui, Feng Yu ^a   Ma, Tian Tai ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; DNA ladder; Immunotherapy; Multiple myeloma; Polyclonal antibodies

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PLASMACYTOMA CELL IMMUNOGLOBULIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL RABBIT; FLOW CYTOMETRY; MICROSCOPY; MOUSE; MYELOMA; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; IMMUNOGLOBULINS; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MULTIPLE MYELOMA; PLASMACYTOMA; PROTEIN BINDING; RABBITS;

MURINAE; MUS; ORYCTOLAGUS CUNICULUS;

EID: 79955759407     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0568-7     Document Type: Article

References (36)

1. SV Rajkumar MA Gertz RA Kyle PR Greipp 2002 Current therapy for multiple myeloma Mayo Clin Proc 77 8 813 824 12173715 10.4065/77.8.813 1:CAS:528:DC%2BD38XmsF2rtrk%3D
2. RA Kyle SV Rajkumar 2008 ASH 50th anniversary review: multiple myeloma Blood 111 6 2962 2972 18332230 10.1182/blood-2007-10-078022 1:CAS:528: DC%2BD1cXjvVamt7w%3D
3. M Rescigno F Avogadri G Curigliano 2007 Challenges and prospects of immunotherapy as cancer treatment BBA-Rev Cancer 1776 1 108 123 1:CAS:528:DC%2BD2sXpvFWmsLw%3D (Pubitemid 47332077)
4. J Rosenblatt D Avigan 2008 Cellular immunotherapy for multiple myeloma Best Pract Res Clin Haematol 21 3 559 577 18790455 10.1016/j.beha.2008.07.007 1:CAS:528:DC%2BD1cXhtFanurrN
5. Y Tanaka-Harada M Kawakami Y Oka A Tsuboi T Katagiri E Olga, et al. 2010 Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ Tcells in patients with myeloid malignancies Cancer Sci 101 594 600 20132220 10.1111/j.1349-7006.2009.01453.x 1:CAS:528:DC%2BC3cXjs1Kks7s%3D
6. L Mileshkin HM Prince JF Seymour JJ Biagi 2003 Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomide Br J Haematol 123 4 747 748 14616984 10.1046/j.1365-2141.2003.04677.x (Pubitemid 37468076)
7. A Jalili S Ozaki T Hara H Shibata T Hashimoto M Abe, et al. 2005 Induction of HM1. 24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma Blood 106 10 3538 3545 16037388 10.1182/blood-2005-04-1438 1:CAS:528:DC%2BD2MXht1ehsb3N (Pubitemid 41609191)
8. SP Treon LM Pilarski AR Belch A Kelliher FI Preffer Y Shima, et al. 2002 CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications J Immunother 25 1 72 81 11924912 10.1097/00002371-200201000-00008 (Pubitemid 34052837)
9. YT Tai LP Catley CS Mitsiades R Burger K Podar R Shringpaure, et al. 2004 Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications Cancer Res 64 8 2846 2852 10.1158/0008-5472.CAN-03-3630 1:CAS:528:DC%2BD2cXjtV2ltbg%3D (Pubitemid 38500624)
10. S Kumar TK Kimlinger JA Lust K Donovan TE Witzig 2003 Expression of CD52 on plasma cells in plasma cell proliferative disorders Blood 102 1075 1077 12714489 10.1182/blood-2002-12-3784 1:CAS:528:DC%2BD3sXlvFCmtL8%3D (Pubitemid 36917808)
11. M Chatterjee T Chakraborty P Tassone 2006 Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy Eur J Cancer 42 11 1640 1652 16797969 10.1016/j.ejca.2006.02.016 1:CAS:528: DC%2BD28Xns1GrtL4%3D (Pubitemid 44118766)
12. M Mihara M Shiina N Nishimoto K Yoshizaki T Kishimoto KI Akamatsu 2004 Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis J Rheumatol 31 6 1132 1138 15170926 1:CAS:528:DC%2BD2cXlsFWgt7w%3D (Pubitemid 38715889)
13. MM Timm TK Kimlinger JL Haug MP Kline PR Greipp SV Rajkumar, et al. 2006 Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma Leukemia 20 10 1863 1869 16932343 10.1038/sj.leu.2404359 1:CAS:528:DC%2BD28XhtVOlsbbI (Pubitemid 44574997)
14. GP Adams LM Weiner 2005 Monoclonal antibody therapy of cancer Nat Biotechnol 23 9 1147 1158 16151408 10.1038/nbt1137 1:CAS:528: DC%2BD2MXpvVyrtr0%3D (Pubitemid 41486396)
15. T Hideshima C Mitsiades G Tonon PG Richardson KC Anderson 2007 Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets Nat Rev Cancer 7 8 585 598 17646864 10.1038/nrc2189 1:CAS:528:DC%2BD2sXotVKqsrw%3D (Pubitemid 47106630)
16. MS Zand T Vo T Pellegrin R Felgar JL Liesveld JJ Ifthikharuddin, et al. 2006 Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin Blood 107 7 2895 2903 16368890 10.1182/blood-2005-06-2269 1:CAS:528:DC%2BD28XjtlKks7w%3D
17. T Watanabe Y Yagi D Pressman 1971 Antibody against neoplastic plasma cells: I. specific surface antigens on mouse myeloma cells J Immunol 106 5 1213 1221 5574404 1:STN:280:DyaE3M7osFOgsg%3D%3D
18. IM Sainz I Isordia-Salas RG Espinola WK Long RA Pixley RW Colman 2006 Multiple myeloma in a murine syngeneic model: modulation of growth and angiogenesis by a monoclonal antibody to kininogen Cancer Immunol Immunother 55 7 797 807 16187087 10.1007/s00262-005-0068-8
19. D Trizio G Cudkowicz 1974 Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo J Immunol 113 4 1093 1097 1:STN:280:DyaE2M%2FhsVylsw%3D%3D
20. Y Wei X Zhao Y Kariya H Fukata K Teshigawara A Uchida 1994 Induction of apoptosis by quercetin: involvement of heat shock protein Cancer Res 54 18 4952 4957 8069862 1:CAS:528:DyaK2cXlvFGhtrk%3D (Pubitemid 24289427)
21. G Damaj M Mohty N Vey E Dincan R Bouabdallah C Faucher, et al. 2004 Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center Eur J Haematol 73 6 402 406 15522061 10.1111/j.1600-0609.2004.00331.x 1:STN:280:DC%2BD2crltVOisQ%3D%3D (Pubitemid 39564362)
22. H Borghaei MR Smith KS Campbell 2009 Immunotherapy of cancer Eur J Pharmacol 625 41 54 19837059 10.1016/j.ejphar.2009.09.067 1:CAS:528: DC%2BD1MXhsVGmtb7K
23. LM Weiner MV Dhodapkar S Ferrone 2009 Monoclonal antibodies for cancer immunotherapy Lancet 373 9668 1033 1040 19304016 10.1016/S0140-6736(09)60251-8 1:CAS:528:DC%2BD1MXjsVOnt7g%3D
24. P Kapoor PT Greipp WG Morice SV Rajkumar TE Witzig PR Greipp 2008 Anti-CD20 monoclonal antibody therapy in multiple myeloma Br J Haematol 141 2 135 148 18318769 10.1111/j.1365-2141.2008.07024.x 1:CAS:528:DC%2BD1cXlsV2mur0%3D (Pubitemid 351406208)
25. I Melero S Hervas-Stubbs M Glennie DM Pardoll L Chen 2007 Immunostimulatory monoclonal antibodies for cancer therapy Nat Rev Cancer 7 2 95 106 17251916 10.1038/nrc2051 1:CAS:528:DC%2BD2sXotFOjtQ%3D%3D (Pubitemid 46160986)
26. YT Tai X Li X Tong D Santos T Otsuki L Catley, et al. 2005 Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma Cancer Res 65 13 5898 5908 15994968 10.1158/0008-5472. CAN-04-4125 1:CAS:528:DC%2BD2MXlslOqt74%3D (Pubitemid 40911196)
27. J Lundin E Kimby M Bjorkholm PA Broliden F Celsing V Hjalmar, et al. 2002 Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL) Blood 100 3 768 773 12130484 10.1182/blood-2002-01- 0159 1:CAS:528:DC%2BD38XlvVCltrg%3D (Pubitemid 34832599)
28. Q Zhang G Chen X Liu Q Qian 2007 Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy Cell Res 17 2 89 99 17242688 10.1038/sj.cr.7310143 1:CAS:528:DC%2BD2sXhslWgsrw%3D (Pubitemid 46279233)
29. C Newcombe AR Newcombe 2007 Antibody production: polyclonal-derived biotherapeutics J Chromatogr B 848 1 2 7 10.1016/j.jchromb.2006.07.004 1:CAS:528:DC%2BD2sXislWmu7g%3D (Pubitemid 46394540)
30. W Matsui Q Wang JP Barber S Brennan BD Smith I Borrello, et al. 2008 Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance Cancer Res 68 1 190 197 18172311 10.1158/0008-5472.CAN-07-3096 1:CAS:528:DC%2BD1cXoslSi (Pubitemid 351380120)
31. J Sharon MA Liebman BR Williams 2005 Recombinant polyclonal antibodies for cancer therapy J Cell Biochem 96 2 305 313 16052504 10.1002/jcb.20536 1:CAS:528:DC%2BD2MXhtFajurvN (Pubitemid 41437863)
32. AH Wyllie 1992 Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview Cancer Metastasis Rev 11 2 95 103 1394797 10.1007/BF00048057 1:STN:280:DyaK3s%2FgvVKrtQ%3D%3D
33. MJ Arends RG Morris AH Wyllie 1990 Apoptosis. The role of the endonuclease Am J Pathol 136 3 593 608 2156431 1:CAS:528:DyaK3cXitlems74%3D (Pubitemid 20105927)
34. MC Raff 1992 Social controls on cell survival and cell death Nature 356 397 400 1557121 10.1038/356397a0 1:STN:280:DyaK383ht1Cmtg%3D%3D
35. BC Trauth C Klas AM Peters, et al. 1989 Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 245 4915 301 305 2787530 10.1126/science.2787530 1:CAS:528:DyaL1MXltlajtLY%3D (Pubitemid 19196649)
36. FA Ayuk N Atassi G Schuch S Mina L Fang C Bokemeyer, et al. 2008 Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia Leukemia Res 32 8 1200 1206 10.1016/j.leukres.2007.12.011 1:CAS:528:DC%2BD1cXlvVSqs7s%3D